Celldex Therapeutics sell Barclays PLC
Start price
17.12.25
/
50%
€21.80
Target price
17.12.26
€20.43
Performance (%)
17.43%
Price
27.02.26
€25.60
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 17.43%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 29.293% | 29.293% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Barclays_PLC for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target raised by analysts at Barclays PLC from $21.00 to $24.00. They now have an "underweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Barclays_PLC for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€20.80
11.11.25
11.11.25
€18.18
11.11.26
11.11.26
23.08%
27.02.26
27.02.26
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.20
13.10.25
13.10.25
€21.52
13.10.26
13.10.26
10.34%
27.02.26
27.02.26